tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Dave Dai, 83 are a BUY (100%).
Analyst Dave Dai, currently employed at SMBC NIKKO,
Dave Dai’s has documented 4 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ACET, Adicet Bio at 31-Mar-2022.
Analyst best performing recommendations are on INBX (INHIBRX ).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
1 months 22 days ago
(21-Aug-2025)
4/6 (66.67%)
$4.74 (21.29%)
118
Buy
$46
$10.35 (29.03%)
$46
2 years 7 months 7 days ago
(06-Mar-2023)
0/4 (0%)
$22.03 (91.91%)
Buy
$40
$9.67 (31.88%)
3 years 6 months 27 days ago
(16-Mar-2022)
0/1 (0%)
$17.23 (75.67%)
Buy
$53
$21.73 (69.49%)
3 years 11 months 3 days ago
(10-Nov-2021)
1/2 (50%)
$10.05 (23.40%)
271
Buy
$60
$41.65 (226.98%)
$30
4 years 1 days ago
(12-Oct-2021)
1/2 (50%)
$19.48 (75.48%)
78
What Year was the first public recommendation made by Dave Dai?
